Many researchers have investigated public RNA sequencing data and microarray gene profiling data from RCC patients, and found that DUXAP8 was markedly upregulated in RCC tumor tissues compared with adjacent para-tumor tissues (Xu et al., 2017; Huang et al., 2018; Chen et al., 2019). This evidence concerns the gene DUXAP8 and renal cell carcinoma.